Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study
Muscle & Nerve · 2026-06 · 73 (6) · 1016-1024
DOI: 10.1002/mus.70207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 07.03.2026. Verfasst von Keshet Pardo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Rabin Medical Center, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Myasthenia Gravis, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction/Aims Myasthenia gravis (MG) is associated with thymic neoplasms. However, an increased prevalence of extrathymic neoplasms has also been reported. This study aimed to evaluate the rates of malignancy in MG patients while accounting for risk factors such as disease characteristics and immunomodulatory treatments.
Methods
We conducted a case–control study using the Clalit Health Services database, applying a machine learning (ML) algorithm to minimize diagnosis misclassification. We included MG patients aged 18 years and older, with a sex‐ and age‐matched control group in a 1:3 ratio. We compared the prevalence and hazard ratios of extrathymic neoplasms between the groups.
Results
A total of 1558 patients with a high probability of MG, according to our ML model, were included in the cohort, alongside a control group of 4674 individuals. MG patients had a higher prevalence of malignancy prior to MG diagnosis, with an odds ratio of 1.95 (95% CI, 1.65–2.08), and a higher incidence of malignancy after MG diagnosis, with a hazard ratio of 1.56 (95% CI, 1.38–1.77). The most prevalent extrathymic neoplasms after MG diagnosis were respiratory, intrathoracic, skin (specifically non‐melanoma), urinary tract, soft tissue, and myelodysplastic syndrome. Risk factors for malignancy included age, male sex, and thymoma. Immunosuppressive treatment did not increase the risk of malignancy.
Discussion
MG patients have a higher prevalence of both solid and hematologic neoplasms compared to non‐myasthenic controls, regardless of immunosuppressive treatment. This supports the notion that malignancy is related to MG disease itself rather than external factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Rabin Medical Center, Petach Tikva, Israel.
- Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.
- Statistical Consultant, Rabin Medical Center, Petach Tikva, Israel.
- Beilinson Medical Center Innovation, Artificial Intelligence Center, Rabin Medical Center, Petah Tikva, Israel.
- Faculty of Computer Science, Reichman University, Herzliya, Israel.
- Department of Cardiology, Rabin Medical Center (Beilinson Campus), Petah Tikva, Israel.
ORCID-Profile: Keshet Pardo, Itay Lotan, Eitan Auriel, Adi Wilf-Yarkoni
Zitieren
APA
Pardo, K., Kab, T., Hellmann, M. A., Lotan, I., Shochat, T., Loebl, N., Yacobi, B., Friedman, Y., Perl, L., Shimon, N., Weisband, Y. L., Bieber, L., Auriel, E., & Wilf-Yarkoni, A. (2026). Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study. Muscle & Nerve, 73(6), 1016-1024. https://doi.org/10.1002/mus.70207
Vancouver
Pardo K, Kab T, Hellmann MA, Lotan I, Shochat T, Loebl N, et al. Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study. Muscle & Nerve. 2026;73(6):1016-1024. doi:10.1002/mus.70207
BibTeX
@article{Pardo2026,
author = {Pardo, Keshet and Kab, Tasneem and Hellmann, Mark A and Lotan, Itay and Shochat, Tzippy and Loebl, Nadav and Yacobi, Bar and Friedman, Yitzhak and Perl, Leor and Shimon, Nitai and Weisband, Yiska Loewenberg and Bieber, Liya and Auriel, Eitan and Wilf-Yarkoni, Adi},
title = {Increased Prevalence of Extrathymic Neoplasms in Myasthenia Gravis Patients‐A Population‐Based, Matched Case–Control Study},
journal = {Muscle & Nerve},
year = {2026},
volume = {73},
number = {6},
pages = {1016--1024},
doi = {10.1002/mus.70207}
}
EUVIMED